Tsutomu Sakurada, Masanobu Miyazaki, Masaaki Nakayama, Yasuhiko Ito
{"title":"Peritoneal dialysis-related infections in elderly patients.","authors":"Tsutomu Sakurada, Masanobu Miyazaki, Masaaki Nakayama, Yasuhiko Ito","doi":"10.1007/s10157-024-02531-5","DOIUrl":null,"url":null,"abstract":"<p><p>This review outlines the epidemiology, characteristics, risk factors, and prognosis of peritoneal dialysis (PD)-related peritonitis, PD catheter-related infections, and the effects of assisted PD in elderly patients from the Japanese perspective. Based on the literature, the incidence of peritonitis is likely to be higher in elderly patients than in younger patients. The most frequent causative bacteria in elderly patients are Gram-positive bacteria, as in adult PD patients, most commonly due to transcatheter infection. However, elderly patients may have difficulty recognizing cloudy drainage fluid due to decreased visual acuity. Hypokalemia, the use of gastric acid suppressants, prophylactic antibiotic use before endoscopy, biocompatible fluids and hypoalbuminemia considered modifiable risk factors for peritonitis. However, the mechanism by which treatment of hypokalemia prevents peritonitis is unknown. Currently, the relationship between gastric acid suppression therapy and peritonitis in elderly patients is debatable, with no evidence to strongly recommend uniform discontinuation of gastric acid suppression therapy. Exit-site infection (ESI) is a major risk factor for the development of peritonitis, and appropriate prevention and management of ESI may reduce infection-related hospitalizations in PD patients. Currently, no randomized, controlled trials have verified the effectiveness of antibiotic application for ESI in Japan, but results from other countries are awaited. In assisted PD, it is extremely important that family members, caregivers, and nurses who support the procedure receive sufficient education and training from medical professionals familiar with PD. Early detection and treatment of PD-related infections are required because the risk of death increases in elderly patients.</p>","PeriodicalId":10349,"journal":{"name":"Clinical and Experimental Nephrology","volume":" ","pages":"1065-1074"},"PeriodicalIF":2.2000,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical and Experimental Nephrology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1007/s10157-024-02531-5","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/6/25 0:00:00","PubModel":"Epub","JCR":"Q2","JCRName":"UROLOGY & NEPHROLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
This review outlines the epidemiology, characteristics, risk factors, and prognosis of peritoneal dialysis (PD)-related peritonitis, PD catheter-related infections, and the effects of assisted PD in elderly patients from the Japanese perspective. Based on the literature, the incidence of peritonitis is likely to be higher in elderly patients than in younger patients. The most frequent causative bacteria in elderly patients are Gram-positive bacteria, as in adult PD patients, most commonly due to transcatheter infection. However, elderly patients may have difficulty recognizing cloudy drainage fluid due to decreased visual acuity. Hypokalemia, the use of gastric acid suppressants, prophylactic antibiotic use before endoscopy, biocompatible fluids and hypoalbuminemia considered modifiable risk factors for peritonitis. However, the mechanism by which treatment of hypokalemia prevents peritonitis is unknown. Currently, the relationship between gastric acid suppression therapy and peritonitis in elderly patients is debatable, with no evidence to strongly recommend uniform discontinuation of gastric acid suppression therapy. Exit-site infection (ESI) is a major risk factor for the development of peritonitis, and appropriate prevention and management of ESI may reduce infection-related hospitalizations in PD patients. Currently, no randomized, controlled trials have verified the effectiveness of antibiotic application for ESI in Japan, but results from other countries are awaited. In assisted PD, it is extremely important that family members, caregivers, and nurses who support the procedure receive sufficient education and training from medical professionals familiar with PD. Early detection and treatment of PD-related infections are required because the risk of death increases in elderly patients.
这篇综述从日本的角度概述了腹膜透析(PD)相关腹膜炎、腹膜透析导管相关感染的流行病学、特征、风险因素和预后,以及辅助腹膜透析对老年患者的影响。根据文献资料,老年患者腹膜炎的发病率可能高于年轻患者。与成年腹膜透析患者一样,老年患者最常见的致病菌是革兰氏阳性菌,最常见的原因是经导管感染。然而,老年患者由于视力下降,可能难以识别浑浊的引流液。低钾血症、使用胃酸抑制剂、内镜检查前预防性使用抗生素、生物相容性液体和低白蛋白血症被认为是腹膜炎的可改变风险因素。然而,治疗低钾血症预防腹膜炎的机制尚不清楚。目前,胃酸抑制疗法与老年患者腹膜炎之间的关系尚存争议,没有证据强烈建议统一停止胃酸抑制疗法。出口部位感染(ESI)是腹膜炎发生的主要风险因素,适当预防和处理 ESI 可减少腹膜透析患者因感染而住院的情况。目前,在日本还没有随机对照试验证实应用抗生素治疗 ESI 的有效性,但其他国家的试验结果还在等待中。在辅助腹膜透析过程中,极为重要的一点是,支持手术的家庭成员、护理人员和护士必须接受熟悉腹膜透析的医疗专业人员提供的充分教育和培训。由于老年患者的死亡风险增加,因此需要及早发现和治疗与腹膜透析相关的感染。
期刊介绍:
Clinical and Experimental Nephrology is a peer-reviewed monthly journal, officially published by the Japanese Society of Nephrology (JSN) to provide an international forum for the discussion of research and issues relating to the study of nephrology. Out of respect for the founders of the JSN, the title of this journal uses the term “nephrology,” a word created and brought into use with the establishment of the JSN (Japanese Journal of Nephrology, Vol. 2, No. 1, 1960). The journal publishes articles on all aspects of nephrology, including basic, experimental, and clinical research, so as to share the latest research findings and ideas not only with members of the JSN, but with all researchers who wish to contribute to a better understanding of recent advances in nephrology. The journal is unique in that it introduces to an international readership original reports from Japan and also the clinical standards discussed and agreed by JSN.